Exploration of novel macrocyclic dipeptide N-benzyl amides as proteasome inhibitors

Add time:07/27/2019    Source:sciencedirect.com

As proteasome inhibitors, a series of novel macrocyclic dipeptide N-benzyl amides were designed, synthesized and evaluated. Most of them exhibited potent proteasome inhibition and excellent anti-proliferative activity against RPMI 8226, MM1S, and MV-4-11 cell lines. As the most distinguished one among this series, compound 23h displayed potent and selective proteasome inhibitory potency (IC50: β5c = 29 nM, β5i = 35 nM, β1c, β2c, β1i, β2i > 10 μM), excellent anti-proliferative activity against RPMI 8226, MM1S, and MV-4-11 cell lines with IC50 values of 18 nM, 15 nM, and 21 nM, respectively, as well as favorable metabolic stability in human liver microsomes (HLMs), highlighting that it is a promising lead compound for further development of proteasome inhibitors.

We also recommend Trading Suppliers and Manufacturers of Benzyl Methyl Carbonate (cas 13326-10-8). Pls Click Website Link as below: cas 13326-10-8 suppliers

Prev:Effect of trifluoromethyl substituents in benzyl-based viologen on the electrochromic performance: Optical contrast and stability
Next:Biodegradable cationic poly(carbonates): Effect of varying side chain hydrophobicity on key aspects of gene transfection)